Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.

Also called NCT06591338

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 900 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06591338
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06591338. Randomized; double masking; primary purpose treatment. Start 2024-09-01 (actual); primary completion 2025-09-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA
Intervention (Drug)
Ticagrelor 90 MG
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Aspirin 75 Mg Oral Tablet
Intervention (Drug)
Aspirin 75 Mg Oral Tablet
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06591338
Content hash
22a4e104952c4c26755b5a17ba44b36c397d5008a7ff1dafd9682604c32e4667